CountryOfPapers CountryOfPapers
Journal list Promote
verified COP 3,6 · Q2 • database Scopus / SJR & Web of Science & DOAJ indexed
Lung Cancer: Targets and Therapy
New Zealand · Dove Medical Press Ltd.
workspace_premium Q2 — Oncology visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Lung Cancer: Targets and Therapy

Lung Cancer: Targets and Therapy is a journal indexed in SJR in Oncology with an H index of 29. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1602 €. The scope of the journal is focused on lung cancer, palliative care, cancer screening. It has a COP Index of 3,6 (best band Q2). It is published in English. It has a COP Index of 3,6.

Publisher: Dove Medical Press Ltd.
Category: Oncology
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
COP Index trending_up
3,6 Q2

85 of 322 journals in Oncology

H-index · SJR 29 · 1,415
Acceptance rate pie_chart
41%
Source Acceptance_Rate
Time to publication hourglass_top
16 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
1.602 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

COP Index

3,6

Q2

SJR Impact

1,415

H-index

29

Docs (year)

19

Docs 3y

34

Total refs

608

Cites 3y

149

Citable 3y

26

Cites/Doc 2y

3.4

Ref/Doc

32.0

Immediate OA

1602 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the COP Index of Lung Cancer: Targets and Therapy?

Lung Cancer: Targets and Therapy has a COP Index of 3,6 (Q2), ranked 85 of 322 in Oncology. SJR: 1,415.

What is the APC / publication cost?

Immediate OA APC is 1602 EUR.

What is the acceptance rate?

The acceptance rate recorded for Lung Cancer: Targets and Therapy is 41%.